Auxeira Startup Success Engine: A Randomized Controlled Trial to Reduce Startup Failure Rates
How to cite
Luthuli, Emmanuel. 2025. "Auxeira Startup Success Engine: A Randomized Controlled Trial to Reduce Startup Failure Rates." AEA RCT Registry. AEARCTR-0016444. https://doi.org/10.1257/rct.16444-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
The global startup failure rate of 90% within three years, costing over $1 trillion annually, highlights systemic inefficiencies in early-stage venture development. The Auxeira Startup Success Engine (SSE) is an AI-blockchain platform delivering dynamic, verifiable incentives to enhance startup success across Market Access, Management, Funding, and Operations. Using AI-driven analytics and blockchain-secured transparency, Auxeira SSE integrates with tools like Stripe and QuickBooks to provide real-time performance insights, targeting a 50% reduction in failure rates and a 20% increase in investor IRR by 2030. A Randomized Controlled Trial (RCT) with 2,000 early-stage startups (1,000 treatment, 1,000 control) will validate its impact on a Sustainable Success Index (SSI), measuring product-market fit, operational efficiency, and investor readiness. Designed for global scalability, especially in emerging markets, Auxeira SSE aims to unlock $500 billion in economic value. We seek collaborators and feedback to refine this transformative platform. Keywords: Startup success, AI, blockchain, RCT, venture capital, entrepreneurship, impact investing.
Intervention
This intervention evaluates the effect of the Auxeira platform—an AI- and blockchain-powered system that delivers real-time, milestone-based incentives to startups in emerging markets. Participating startups will be onboarded to the Auxeira platform, which autonomously tracks key performance indicators (KPIs) and issues rewards (e.g., cloud credits, legal tools) upon verified progress.
Startups are randomized into control and treatment groups. The treatment group gains full access to Auxeira’s automated monitoring, reporting, and incentive distribution system. The control group receives light-touch support and no milestone-based rewards.
The goal is to assess whether the platform improves startup survival rates, operational KPIs, and investor confidence relative to traditional support models.
Experimental design
This is a randomized controlled trial (RCT) involving 2,000 early-stage startups from 10 countries. After baseline data collection, startups are randomly assigned to treatment or control groups. The treatment group receives access to the Auxeira platform with real-time monitoring and automated incentives; the control group receives basic educational materials only. Outcomes are measured 6 and 12 months post-onboarding.
Design details
Cited by
No citation data available for this registration yet.